Entities / Company
Tyra Biosciences.
company in Carlsbad, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 23
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Tyra Biosciences listed its shares on the stock exchange on August 6, 2026.Some support5 reports1 development inside
-
Tyra Biosciences received positive analyst ratings and saw increased investment stakes from Geode Capital Management and BofA.Some support2 reports
-
Tyra Biosciences and Apogee Therapeutics are being compared based on their financial metrics.Some support1 report
-
On August 1, 2026, several firms made moves regarding Tyra Biosciences, including Mirae Asset increasing its position, Caitong buying, and Janus Henderson reducing its stake.Some support1 report
Gone quiet
No new reports in 90+ days-
Tyra Biosciences announced on June 30, 2025, that its study will enroll participants primarily in the US, with the announcement originating from Carlsbad.Speculative1 report
-
Tyra Biosciences presented its results at the ENDO 2025 conference.Speculative1 report
-
Tyra Biosciences is based in Carlsbad, California.Some support1 report
-
Todd Harris has been appointed CEO of Tyra Biosciences.Some support4 reports
No events began in the chosen period. Widen it, or reset.
Around Tyra Biosciences this week
News at the entities that move Tyra Biosciences most-
Manufacturers Life Insurance Company TransactionalManufacturers Life Insurance Company purchased a new stake in Telos shares, a company serving customers in the United States.Moves Tyra Biosciences
-
Geode Capital Management TransactionalGeode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Moves Tyra Biosciences
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Tyra Biosciences
-
Bank of America Mentioned togetherGoldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Moves Tyra Biosciences
-
Jefferies Financial Group Mentioned togetherJefferies reaffirmed Amazon's stock buy rating on June 18, 2026.Moves Tyra Biosciences
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Tyra Biosciences
Connections
The 9 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Todd Harris Structural
Todd Harris serves as the CEO of Tyra Biosciences.
-
Nasdaq Structural
Tyra Biosciences is formally listed on the Nasdaq stock exchange.
-
Geode Capital Management Transactional
Geode Capital Management increased its investment stake in Tyra Biosciences.
-
Securities and Exchange Commission Structural
Tyra Biosciences is engaged in formal regulatory compliance by filing documentation with the Securities and Exchange Commission.
-
Bank of America Mentioned together
Bank of America provided investment coverage for Tyra Biosciences, raising its price objective and issuing a 'buy' rating.
-
MarketBeat Mentioned together
MarketBeat lists Tyra Biosciences as a growth stock, placing it within a thematic group of high-growth companies.
-
Jefferies Financial Group Mentioned together
Jefferies provided market coverage by reaffirming a buy rating and price target for Tyra Biosciences.
-
Manufacturers Life Insurance Company Transactional
Manufacturers Life Insurance Company purchased a new position in shares of Tyra Biosciences.
Show all 9 connections
-
Carlsbad Shared context
Tyra Biosciences is located and conducts trials in Carlsbad, California.
History
Events by the month they beganAugust 2026
4 events- Tyra Biosciences listed its shares on the stock exchange on August 6, 2026.
- Tyra Biosciences received positive analyst ratings and saw increased investment stakes from Geode Capital Management and BofA.
- Tyra Biosciences and Apogee Therapeutics are being compared based on their financial metrics.
- On August 1, 2026, several firms made moves regarding Tyra Biosciences, including Mirae Asset increasing its position, Caitong buying, and Janus Henderson reducing its stake.
June 2026
4 events- Tyra Biosciences announced on June 30, 2025, that its study will enroll participants primarily in the US, with the announcement originating from Carlsbad.
- Tyra Biosciences presented its results at the ENDO 2025 conference.
- Tyra Biosciences is based in Carlsbad, California.
- Todd Harris has been appointed CEO of Tyra Biosciences.